July, 2024

article thumbnail

Embracing Digital Transformation: How Pharmacies Can Thrive in an Evolving Health Care Landscape

Pharmacy Times

Pharmacies can adapt by embracing digital self-service options to better engage with patients, meet increasing consumer demand, and enhance revenue streams.

139
139
article thumbnail

CVS PBM to Pay $45 Million in Rebates to State of Illinois

Drug Topics

CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.

666
666
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could pharma’s blockbuster immunotherapies work in dogs?

PharmaVoice

Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals.

279
279
article thumbnail

Discovering My Path: My Journey as a Pharmacy Student at the University of Findlay

Pharmacy Is Right For Me

Hey there, future pharmacists! I’m Shelby, a student pharmacist at the University of Findlay (UF), and I’m here to share my journey with you. If you’re thinking about a career in pharmacy or just curious about what it’s like, you’re in the right place! Falling in Love with Findlay My adventure started the summer before my senior year of high school at Findlay’s Summer Pharmacy Camp.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Mount Sinai mounted aggressive campaign to stifle debate over revelations about its controversial brain research

STAT

Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes campaign to blunt the fallout over revelations about its controversial research project in which brain biopsies are taken from patients undergoing deep brain stimulation, STAT has learned. That has included not only enlisting its own patients to defend the research but also seeking to stop a professional society of neurosurgeons from issuing a statement that could have jeopardized the researc

article thumbnail

Optum lays off more employees at Landmark, OptumInsight

Fierce Healthcare

The sprawling enterprise that is UnitedHealth Group is undergoing more layoffs under its Optum umbrella. | UnitedHealth's Optum is again laying off workers, with the scope unconfirmed. Landmark Health is downsizing once again and leaving major metropolitan areas.

141
141

More Trending

article thumbnail

PBM Reform Law Aims to Support Local Pharmacies in Pennsylvania

Drug Topics

House Bill (HB) 1993 seeks to increase PBM transparency and accountability in an effort to combat the rising cost of prescription drugs.

595
595
article thumbnail

Has pharma emerged from the ‘age of uncertainty’?

PharmaVoice

An industry reeling from a precarious market is showing signs of stabilizing as the future becomes a little less cloudy, an Evaluate report suggests.

264
264
article thumbnail

How NVIDIA grew with the healthcare market instead of pushing into it

Pharmaceutical Technology

As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.

137
137
article thumbnail

Vision loss and high cholesterol identified as risk factors for dementia

STAT

Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable risk factors for dementia in a report released Wednesday by the Lancet Commission. These new additions join 12 other risk factors outlined by the commission, affiliated with University College London, in previous reports on dementia prevention, intervention, and care in 2017 and 2020.

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Humana inks multi-year partnership with Google to invest deeper in cloud, gen AI technologies

Fierce Healthcare

Humana inked a new multi-year agreement with Google Cloud to modernize its cloud infrastructure and build out generative AI solutions. | Humana inked a new multi-year agreement with Google Cloud to modernize its cloud infrastructure and build out generative AI solutions.

141
141
article thumbnail

Vonoprazan FDA Approved for Heartburn Relief Associated with Non-Erosive Gastroesophageal Reflux Disease

Pharmacy Times

A large portion of the population of patients in the United States with GERD have the non-erosive type of the disease.

FDA 160
article thumbnail

The Girls Are Back: One Pharmacist’s Journey to Save His Community Pharmacy

Drug Topics

Mayank Amin, PharmD, RPh, MBA, sat down with Drug Topics on part 1 of an episode of Over the Counter to share his experiences transforming a shuttered independent pharmacy into a thriving community hub.

article thumbnail

BMS’ long-standing leukemia blockbuster stares down its first generic

PharmaVoice

Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.

264
264
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Health Care Providers Increasingly Believe Pharmacists Should Take on More Primary Care Duties

Drug Topics

A survey conducted by Surescripts, a health care solutions company, explored the attitudes of pharmacists and prescribers towards ongoing issues and challenges currently facing the industry.

530
530
article thumbnail

Continuous Glucose Monitors Help Reduce A1c in Patients with Diabetes

Drug Topics

Research presented at the American Diabetes Association 84th Scientific Sessions suggests a population approach to CGM use could be beneficial.

532
532
article thumbnail

Is LTC Pharmacy Going Back to the Future?

Drug Topics

Drug Topics sat down with Sandra Canally, RN, founder and CEO of The Compliance Team, and Kara Benson, PharmD, long-term care director of Lewis Drug Inc, to discuss the future of LTC pharmacy.

529
529
article thumbnail

Rite Aid Addresses Cyberattack: 2.2 Million Customers’ Data Breached

Drug Topics

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

526
526
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Democrats, Republicans Come Together to Condemn PBMs

Drug Topics

In a House Committee on Oversight and Accountability hearing, Democrats and Republicans took a bipartisan stance to question the role major PBMs play regarding rising drug costs in the US.

504
504
article thumbnail

Slideshow: Managing The Peak of Asthma Season

Drug Topics

The American College of Allergy, Asthma, and Immunology (ACAAI) recently released its 5 tips to help children and their parents stay educated on asthma peak month.

503
503
article thumbnail

Q&A: US Army Veteran Discusses His Experience with PTSD

Drug Topics

A former sergeant first class in the US Army discussed PTSD in an exclusive interview with Drug Topics.

504
504
article thumbnail

Overcoming PTSD: Farron Dozier Discusses His Experience in the US Army

Drug Topics

Farron Dozier, former sergeant first class in the US Army, sat down with Drug Topics on a recent episode of Over the Counter to discuss his experience with PTSD.

502
502
article thumbnail

Q&A: What the NCPA is Doing to Fight Back Against PBMs

Drug Topics

Steve Postal, JD, Director of Policy and Regulatory Affairs at the National Community Pharmacists Association (NCPA), discussed pharmacy benefit managers and vehicles necessary to induce reform.

502
502
article thumbnail

Semaglutide Use Increases Risk of Optic Neuropathy

Drug Topics

Researchers addressed the association between semaglutide use and the risk of nonarteritic anterior ischemic optic neuropathy.

501
501
article thumbnail

Bird Flu Virus Spreads in Dairy Cattle, But Human Health Risk Remains Low

Drug Topics

The CDC issued a report on the state of the avian influenza, or bird flu, at the end of last week.

498
498
article thumbnail

Mediterranean, DASH Diets May Lower Risk of Cardiovascular Disease in Patients with T1D

Drug Topics

Individuals who ate diets that aligned closer to DASH and Mediterranean guidelines had lower levels of plasminogen activator inhibitor-1 and homocysteine biomarkers.

493
493
article thumbnail

Drug Topics Top 10: Most Read Stories From July 2024

Drug Topics

Check out this list of our top 10 most read stories from July 2024.

485
485
article thumbnail

Drug Advertising, Disease Awareness Misconstrue Patients’ Understanding of Pharmaceutical Benefits

Drug Topics

Researchers aimed to determine the risks and benefits of prescription drug advertising released in tandem with disease awareness programming.

469
469
article thumbnail

COVID-19 Infection Associated with Long-Term Impact on Immune System

Drug Topics

COVID-19 patients had reduced absolute granulocyte, monocyte, and lymphocyte counts at 10 months post-infection compared to noninfected individuals.

article thumbnail

Monoclonal Antibody to Prevent RSV in Infants Shows Positives Results in Phase 2b/3 Study

Drug Topics

MK-1654 (clesrovimab) met its primary efficacy endpoint of incidence of patients with RSV-associated medically attended lower respiratory infections (MALRI) through Day 150.

379
379
article thumbnail

Phase 1/2 Trial of Investigational Herpes Zoster Vaccine Candidate Underway

Drug Topics

Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.

Vaccines 377
article thumbnail

Maternal RSV Vaccination Not Associated With Increased Preterm Birth Risk

Drug Topics

Current recommendations suggest women receive the RSV vaccine between 32 and 36 weeks' gestational age.

Vaccines 365
article thumbnail

SGLT2i, GLP-1RA Combination Therapy Offers Robust Protection Against Cardiovascular, Kidney Disease

Drug Topics

When used together, sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were able to lower the risk of major adverse cardiovascular events and kidney disease by 11% and 33%, respectively.

343
343